Nathan: Non-Prescription Medicines 4th Edition






In this book, OTC (over the counter) medicines currently available in the UK are reviewed in alphabetically arranged chapters on the conditions for which they are licensed to treat. This book will also be of value to pharmacists and other health professionals in the Republic of Ireland, because most of the proprietary branded medicines available in the UK are also available under the same name in Ireland. Also, patients from the UK, including from Northern Ireland, often ask for UK products, and these products are familiar as transnational advertising raises awareness. The classification of non-prescription medicines in Ireland is generally similar to that it in the UK, but due to licensing restrictions some medicines that are available without prescription in the UK are not in Ireland.

Information is provided on the following aspects of products:
  • compounds or constituents,
  • mode of action,
  • indications,
  • evidence of efficacy,
  • side-effects,
  • cautions and contraindications,
  • interactions,
  • dosage,
  • presentations and formulations,
  • products available and manufacturers (either all products in a category or, for categories where there are a large number of products, a representative selection),
  • each section concludes with a summary of key points and suggestions for the most appropriate products to recommend.

Evidence of the efficacy of medicines is cited where it exists. However, few clinical trials on medicines for OTC use have been published, and most of the available evidence comes from the use of medicines as POMs before their reclassification to P status. In some instances, medicines are licensed for nonprescription use for different indications and at different doses from their use as prescription drugs, and caution may therefore be necessary in extrapolating clinical trial evidence to OTC use. There is very little clinical trial evidence for medicines that were already licensed for OTC use before POM-to-P reclassifications began. Such trials as could be found and appear to meet current methodological standards are cited.

This edition has been completely revised and brought up to date. New products have been included and assessed, and discontinued products have been deleted. New chapters on chlamydia obesity, and benign prostatic hyperplasia have been added.

A feature introduced with the last edition - the publication of 6-monthly updates on the Pharmaceutical Press website (www.pharmpress.com/onlineresources) - is continued with this edition.
- The Author -


Contents 
  • 1 Acne
  • 2 Athlete's foot
  • 3 Benign prostatic hyperplasia
  • 4 Cardiovascular medicines
  • 5 Chlamydia (Chlamydia trachomatis infection)
  • 6 Colds
  • 7 Cold sores
  • 8 Constipation
  • 9 Corns and calluses
  • 10 Cough
  • 11 Cradle cap
  • 12 Cystitis
  • 13 Dandruff and seborrhoeic dermatitis
  • 14 Diarrhoea
  • 15 Dry skin
  • 16 Ear problems
  • 17 Emergency hormonal contraception
  • 18 Eye conditions
  • 19 Fungal nail infection (onychomycosis)
  • 20 Haemorrhoids
  • 21 Hay fever
  • 22 Head lice
  • 23 Indigestion
  • 24 Insect bites and stings
  • 25 Irritable bowel syndrome
  • 26 Irritant and allergic dermatitis and mild eczema
  • 27 Migraine
  • 28 Motion sickness
  • 29 Mouth ulcers
  • 30 Nappy rash
  • 31 Obesity management
  • 32 Oral thrush
  • 33 Pain
  • 34 Pattern baldness
  • 35 Premenstrual syndrome
  • 36 Scabies
  • 37 Smoking cessation products
  • 38 Sore throat
  • 39 Temporary sleep disturbance
  • 40 Threadworm and roundworm
  • 41 Vaginal candidiasis
  • 42 Vaginitis and vaginal dryness
  • 43 Verrucas
  • 44 Warts
  • Index


About the author
Alan Nathan has extensive experience of both community and academic pharmacy. He has been a locum, employee and proprietor community pharmacist, and for 15 years he was a lecturer in pharmacy practice at the Department of Pharmacy, King’s College London University. Since 2004, Alan has been a freelance pharmacy writer, publishing widely in pharmacy and other health profession journals and the consumer press. He has authored two books: this one and Fast Track: Managing symptoms in the pharmacy (Pharmaceutical Press, 2008). His main areas of writing interest are the management of minor ailments, and pharmacy law and ethics and professionalism. Alan has also been a consultant to several pharmacy organisations and companies. Alan was a member of the Council of the Royal Pharmaceutical Society from 1986 until 2002, and is co-founder and chairman of the Pharmacist Support Listening Friends stress help scheme for pharmacists.


Product Details

  • Paperback: 308 pages
  • Publisher: Pharmaceutical Press; 4 edition (June 2010)
  • Language: English
  • ISBN-10: 0853698864
  • ISBN-13: 978-0853698869
  • Product Dimensions: 9.1 x 6.1 x 0.8 inches
List Price: $55.00 
 
 

Medical Lecture Note Copyright © 2011